The morning news update with Aviva, Merlin Entertainments and Forbidden Technologies
FTSE 100 AstraZeneca (AZN) – the US Food and Drug Administration has accepted for filing the New Drug Application for IRESSA® (gefitinib) as a targeted monotherapy for the first line treatment of patients with advanced or metastatic epidermal growth factor receptor mutation positive non-small cell lung cancer. Aviva (AV.) – Aviva and Friends Life have…